The terminal differentiation of myoblasts begins with their withdrawal from the cell cycle and with various changes of components involving the syntheses of a new set of proteins. The myoblasts then undergo a series of events including cell fusion, and the syntheses and assembly of myofibrillar proteins to form muscle fibers (15, 23, 27, 29) . The onset and progression of this process is controlled by a complex set of interactions between myoblasts and their environment (2, 26, 34) . Someof the regulatory proteins induced within the cell have recently been identified (22, 31) , but little is known about the environmental clues or signals at the membrane that allow differentiation to proceed. Wehave investigated the mechanism of muscle differentiation, especially myoblast fusion, using quail myoblasts transformed with a temperature-sensitive mutant of Rous sarcoma virus (QM-RSV cells) (7, 9, 10, 12, 13, 14, 25) . After transformation with a ts-RSV, the fusion of these cells becomes temperature-sensitive. At 35 .5°C, a permissive temperature for the virus, QMRSVcells proliferate but do not fuse. In contrast, at 41°C, a non-permissive temperature, the cells become committed to differentiate within 10-12 hr, and begin to fuse, forming myotubes within 24 hr. Recently, a monoclonal antibody, H-145, that strongly inhibited myoblast fusion, was obtained in our laboratory and partially characterized as previously reported (10). The antigen reacting with H-145 is a glycoprotein with a molecular mass of 1 16 kDa. This antigen is similar to /31 integrin in its molecular mass and localization on the cell surface. However, the H-145 antigen does not interact with an antibody against /31 subunit of integrin. More recently, meltrin-a, a member of the metalloproteinase/disintegrin protein family, appears to be required for myotube formation (32) . However, H-145 antigen is different from meltrin-a in expression patterns from various tissues and quantitative expression during differentiation. Thus it is suggested that H-145 antigen is different from these components associated with myogenic differentiation. Our recent studies have suggested that an increased reTo whomcorrespondence should be addressed. quirement of the antigen and change of its distribution are important for myoblast fusion during myogenesis (10). H-145 antigen is expressed as early as the presumptive myoblast stage at a low level and its expression increases quantitatively as differentiation progresses. Concomitantly, the distribution of H-145 antigen on the cell surface changes dynamically, showing several quite different patterns, and the strength of H-145 antigen staining appears higher on myotubes than on myoblasts on indirect immunofluorescence staining. Moreover, H-145 antigen is localized not only at the cell surface but also in the cytoplasm. After 24 hr incubation with H-145 at the temperature for differentiation, myoblast fusion was completely inhibited. But on further culture without changing the medium,a few myotubes gradually began to appear. Addition of H-145 completely inhibited myoblast fusion. Thus for preventing myoblast fusion it was necessary to supply the antibody continuously by replacing the medium by fresh differentiation mediumcontaining H-145. These findings strongly suggest that the H-145 antigen is synthesized inside the cell and transported sequentially to the cell surface to maintain continuous differentiation.
This could be one reason whysomemyotubesappear on cells cultured for a long period in the presence of H-145. That is, H-145, which corresponds to newly expressed H-145 antigen during differentiation, should be present continuously at a sufficient level to neutralize the H-145 antigen on the cell surface to maintain its fusion-inhibitory effect during differentiation. One requirement for initiating myoblast fusion may be accumulation of sufficient H-145 antigen on the cell surface, as we proposed previously (10). To investigate this possibility in this study, we examined the relationship between myoblast fusion and expression of H-145 antigen on the cell surface, using inhibitors of cytoplasmic transport of intracellular proteins from the Golgi apparatus to the cell surface.
MATERIALS AND METHODS
Cell culture. QM-RSVcells were originally derived from primary quail myoblasts by Kim et al. (12) . The cells proliferated exponentially in growth medium (GM). Differentiation was induced by replacing GMby differentiation medium (DM) after the cells had been preincubated at 35.5°C for 24 hr, and then culturing them at 41°C. Reagents and antibodies. Bafilomycin Al was kindly provided by Dr. Yamamoto, Department of Physiology and Cell Biology, Liver Research Center, Kansai Medical University, and stored at -80°C as a 1 mMstock solution in dimethylsulfoxide (DMSO) until use. Unless otherwise stated, it was used at 5 nMfinal concentration. A mouse monoclonal antibody H-145 directed against the integral glycoprotein related to myoblast fusion was raised as described previously (10), and was used for immunofluorescence and immunoblot studies. Purified wheat germ agglutinin (WGA) conjugated to tetramethylrhodamine isothiocyanate (TRITC) was purchased from E-Y Laboratories.
Indirect immunofluorescence staining. All immunofluorescence microscopy studies reported here were on QM-RSV cells. Indirect immunofluorescence staining was performed as described previously (10). The Golgi apparatus was then stained with purified WGA-conjugated TRITC (5 jug/ml). Stained preparations were observed with a Zeiss Universal microscope or Zeiss laser scanning con focal microscope (LSCM; Carl Zeiss Inc., Oberkochen, Germany). It can image the location of particular organellae in three dimensions. Estimation offusion-inhibition by bafllomycin Al. QMRSVcells were preincubated in GMat 35.5°C for 24 hr, and then cultured at 41°C in DMwith bafilomycin Al. After 24 hr, DMcontaining bafilomycin Al was replaced by fresh DM without the inhibitor. Cultures were fixed with 2% glutaraldehyde and stained with 0.02% toluidine blue to examine the effect of bafilomycin Al on myoblast fusion by microscopy.
Percentage fusion was determined as described previously (12) .
Assay of creatine kinase. QM-RSV cells were cultured at 41°C for 24 hr in DMwith or without bafilomycin Al. Cell lysates were then prepared and the enzyme was assayed as described previously (12).
Western blotting with H-145 of cell membrane(M) and cytoplasmic (C) fractions from QM-RSVcells. For preparations of cell membrane and cytoplasmic fractions, QM-RSVcells were harvested from culture plates by scraping them into phosphate buffered saline (PBS), and were then washed with buffer A (10mM Tris-HCl, pH7.4, containing 0.25 M sucrose, 1 mMMgCl2, 5 mMCaCl2 and a mixture of protease inhibitors). The cell pellets were suspended in buffer A and homogenized on ice with a Dounce homogenizer as described (5). The homogenate was centrifuged at 600 x g for 10 min to separate unbroken cells and nuclei, and the supernatant was recentrifuged at 100,000 x g for 60 min at 4°C to obtain cytoplasmic and crude membrane fractions. Samples of 50 ptg of protein of each fraction were electrophoresed in 7.5% SDS-PAGE under non-reducing conditions and were subjected to Western blotting as described previously (10).
RESULTS
Dynamic change in distribution ofH-145 antigen during differentiation. As described in a previous paper (10), the distribution of H-145 antigen on the cell surface showed several quite different patterns during differentiation by the indirect immunofluorescence technique. Moreover, Western blot analysis suggested that H-145 antigen is present throughout differentiation, increases during differentiation before myoblast fusion, and persists on myotubes. From these findings, we concluded that the H-145 antigen is actively synthesized in the cells at 41°C, although some of it is present on the of QM-RSVcells. Cells were preincubated at 35.5°C for 24 hr in GM (A), and then cultured at 41°C in DMfor 3 hr (B), 6 hr (C), and 12 hr (D), respectively. Cells were fixed and permeabilized, and then stained with H-145 as described in MATERIALS ANDMETHODS. The fluorescence seen with the focal plane set at the mid-nuclear level was weak in the cytoplasm and prominent around the nucleus as punctate fluorescence in cells cultured at 35.5°C (A). On culture at 41°C, the fluorescence became stronger, and dispersed from the cytoplasm to the cell surface. Bar, 20 //m. surface of the cells at 35.5°C, and that during differentiation, it is transported to the cell surface continuously. So we examined the dynamic movementof H-145 antigen not only on the cell surface but also inside of the cells during differentiation in more detail.
H-145 antigen on the cell surface of viable, unpermeabilized cells was stained by immunofluorescence staining at 4°C. On live cells immediately before shift up to 41°C for differentiation, H-145 staining was weak and was observed as speckles all over the cell surface, and as aggregates at the tips of cells, as described previously (10) . At this time, cytoplasmic H-145 antigen was examined in cells fixed with formaldehyde and permeabilized with Triton X-100, which leaves a cytoskeletal network (3, 4, ll, 24) . Fluorescent staining with H-145 showed that H-145 antigen was located in the cytoplasm. In particular, it was accumulated in particles around the nucleus, which seemed to be the Golgi apparatus. In cells cultured at 41°C for 3 hr, the amount of H-145 antigen localized in the periphery of the nuclei was increased (Fig. IB) , and a discrete punctate distribution of H-145 antigen was seen in the cytoplasm. In cells cultured at 41°C for 6 hr, H-145 antigen was seen not only on the periphery of the nuclei but also widely distributed throughout the cytoplasm (Fig. 1C) . The fluorescence of H-145 antigen at this time was stronger than after culture at 41°C for 3 hr. After culture at 41°C for 12 hr, when the cells became committed to differentiation, fluorescence of H-145 antigen was spread all over the cytoplasm in a diffuse fashion, and was markedly in-creased, although the extent of its expression differed in individual cells (Fig. ID) To further examine the location of H-145 antigen in cells immediately before differentiation, the intracellular distribution of H-145 antigen was analyzed by laser scanning con focal microscopy (LSCM) (Fig. 2) . LSCM makes it possible to focus on fluorescence staining of H-145 antigen at different levels both at the surface and within the cytoplasm. Stained cells were examined by LSCMin the horizontal direction through the center (Fig. 2B ). H-145 antigen was mostly concentrated near the nucleus. Next, the cells were examined in the vertical direction through the nucleus as shown in Fig. 2C . As shown in Fig. 2D , the antigen was seen as fine punctate staining in the periphery of the nuclei of cells (arrow in Fig. 2D ), which seemed to correspond to the Golgi apparatus, with small amounts on the cell surface. Nonuclear staining was observed. These results suggested that most of the antigen was concentrated near the nucleus at 35.5°C. Localization ofH-145 antigen in the Golgi apparatus at35.5°C. As described above, typically prominent accumulation of H-145 antigen was observed in the perinuclear region, probably the Golgi apparatus, in the growth phase. To clarify this point, we used double-labelling indirect immunofluorescence staining with H-145 and wheat germ agglutinin (WGA). WGAcan be used as a marker of Golgi, because it is a lectin with high affinity for the Golgi apparatus (16, 17, 18, 28, 30, 33) . As shown in Fig. 3 , strongly fluorescent perinuclear structures were identified as the Golgi apparatus by H-145 antigen is accumulated in the Golgi apparatus and then transported to the cell surface, and that its expression on the cell surface is required at a sufficient level for myoblast fusion. To obtain supporting evidence for this suggestion, we used bafilomycin Al, which is known to inhibit transport of intracellular proteins from the Golgi apparatus to the cell surface. If transport of H-145 antigen from the Golgi apparatus to the cell surface is associated with myoblast fusion, we can expect that this drug would inhibit myoblast fusion. First we examined the effect of bafilomycin Al on myoblast fusion of QM-RSVcells. For this, QM-RSV cells were cultured in the presence of various concentrations of bafilomycin Al for the first 24 hr at 41°C. As shown in Fig. 4 , bafilomycin Al inhibited myoblast fusion dose-dependently, completely arresting the formation of multinucleated myotubes at a concentration of 5 nM, without detachment of the cells (Fig.  4D) . The cells did not show noticeable abnormalities other than lack of fusion. At higher concentrations of the drug, the cells gradually became detached. Treatment of cells with DMSOdid not inhibit myoblast fusion only at the same concentration as used for addition of bafilomycin Al, as a negative control (Fig. 4A ). In addition, weexamined effects of methylamine, monensin and chloroquine, which are other drugs that are knownas inhibitors of transport of intracellular proteins, on myoblast fusion of QM-RSVcells. All of these inhibitors inhibited myoblast fusion as well (data not shown).
Bafilomycin Al is also reported to be a specific inhibitor ofvacuolar H+-ATPase (1, 6, 8, 19, 20, 21, 35) . To examine whether myoblast fusion by bafilomycin Al was due to inhibition of the H+-ATPase, we used another inhibitor of the H+-ATPase, 2,3-butanedione. When QM-RSV cells were cultured in the presence of 2,3-butanedione, myoblast fusion was inhibited (data not shown). Wenext examined whether inhibition of myoblast fusion was reversed on its removal from the medium. For this, cells were cultured in DMwith bafilomycin Al at 41°C for 24 hr to inhibit myoblast fusion, and then for 24 hr in fresh DMwithout bafilomycin Al. As shown in Fig. 5 , after replacement by fresh DMwithout bafilimycin Al, fusion began after a lag time of about 8 hr. This indicates that inhibition of myoblast fusion by bafilomycin Al was reversible by removal of the drug. These results suggest that blockage of transport of H-145 antigen from the Golgi apparatus to the plasma troscopy. As shown in Fig. 6B , after 24 hr treatment of the cells with bafilomycin Al at 41°C, the pattern of H-145 staining was almost the same as in cells cultured at 35.5°C (Fig. 6A) , being mainly localized in punctate staining round the nucleus. Thus, expression of H-145 antigen on the cell surface was strongly suppressed by the drug. Increase in the H-145 antigen was also suppres- teins, methylamine, monensin and chloroquine, also caused the H-145 antigen to remain in the Golgi apparatus.
Wenext examined whether the transport of H-145 antigen was restored by removal of bafilomycin Al from the medium. Weremoved bafilomycin Al after culture for 24 hr, cultured the cells for a further 8 hr at 41°C in fresh medium, and then observed them by indirect immunofluorescence spectroscopy. As shown in Fig. 6C , H-145 antigen was widely dispersed throughout the cytoplasm and the amount of the antigen on the plasma membranewas increased. These results indicated that the effect of bafilomycin Al is fully reversible, and that quantitative expression of the antigen on the cell surface is closely associated with myoblast fusion. Requirement of quantitative surface expression of the antigen for myoblastfusion. The results described above suggested that bafilomycin Al affects the transport of H-145 antigen, causing its accumulation in the Golgi apparatus. In addition, the amount of H-145 antigen in cells treated with bafilomycin Al at 41°C seemed to be as low as that in cells cultured at 35.5°C. These observations suggest that quantitative expression of H-145 antigen on the cell surface is required for myoblast fusion. To confirm this, weexamined the effect of bafilomycin Al on expression of H-145 antigen on the surface membrane. QM-RSVcells were grown in GMfor 24 hr at 35.5°C, and cultured in DMwith or without bafilomycin Al for 24hr at 41°C. The cell membrane and cytoplasmic fractions were prepared and the H-145 antigen in both fractions was assayed by immunoblotting.
The results are shown in Fig. 7 . In cells grown at 35 .5°C, the amount of H-145 antigen in the cytoplasmic fraction was almost the same as that in the cell membrane fraction (lanes 2 and 3 in Fig. 7) . But in cells cultured at 41°C for 24hr, almost all the H-145 antigen was present in the cell membrane fraction, with scarcely any in the cytoplasmic fraction (lanes 4 and 5 in Fig. 7) . These results also demonstrate that H-145 antigen is present in both the cytoplasm and cell membrane before differentiation, but that on differentiation at 41°C, it becomes predominantly localized in the surface membrane. In contrast, in cells treated with bafilomycin Al , some H-145 antigen was only slightly detectable in the membrane fraction even at 41°C (lane 6 in Fig. 7 ). Thus expression of the antigen on the surface membrane was apparently suppressed by the drug. These results, together with those obtained in immunofluorescencestudies indicate that quantitative expression of the antigen on the cell surface is necessary for myoblast fusion. Effect of bafilomycin A l on biochemical differentiation. During muscle differentiation, biochemical differentiation, involving processes such as the syntheses of muscle-specific proteins and enzymes, occurs concomitantly with myotube formation. In QM-RSVcells, biochemical differentiation, like myoblast fusion, is temper- Fig. 7 . Effect of bafilomycin Al on membrane expression of H-145 antigen. Cells were cultured in DMfor 24 hr at 35.5°C (lanes 2 and 3) or 41°C (lanes 4 and 5), or in DMwith bafilomycin Al at 41°C (lanes 6 and 7). Cytoplasmic (C) (lanes 2, 4, and 6) and cell membrane (M) (lanes 3, 5, and 7) fractions from the cells were prepared as described in MATERIALS ANDMETHODS. Fractions were analyzed by immunoblotting with H-145. Lane 1 represents prestained molecular weight standards. At 41°C, most of the H-145 antigen was localized in the membranes, but on treatment with bafilomycin Al, transport of the antigen to the cell surface was inhibited. The arrow shows material of 116 kDa, the molecular weight of H-145 antigen. ature-sensitive; with initiation of fusion, there is a rapid increase in the activity of creatine kinase (12), so creatine kinase activity is routinely used as a biochemical marker of myogenic differentiation. Thus to determine whether bafilomycin Al affects biochemical differentiation as well as myoblast fusion, we measuredthe creatine kinase activity in cells cultured at 41°C in the presence of bafilomycin Al. In the control culture, creatine kinase activity was increased after 24 hr to about 5-fold that in cells before differentiation.
When QM-RSVcells were treated with bafilomycin Al for 24 hr, the enzyme activity was suppressed about 50% (Table I) , being about 2.4-fold that in cells before differentiation.
DISCUSSION
As reported previously, a monoclonal antibody, H-145, strongly inhibits myoblast fusion, and its antigen is constantly expressed at a low level even in presumptive myoblasts (10). The antigen increases in cells on incubation at 41°C, the temperature for differentiation. This antigen shows a unique and dynamic change in distribution during differentiation. Continuous supplementation of the antibody was required for complete inhibition of myoblast fusion. These results suggest that quantitative expression of the antigen is needed for fusion. To confirm this and to obtain a clue to the biological significance of the antigen, we examined the relationship between the expression of the antigen on the cell surface and the differentiation process in detail. At 35.5°C, most of the H-145 antigen was detected near the periphery of nuclei, the region of the Golgi apparatus in presumptive myoblasts, with only slight expression on the cell surface. At 41°C, a temperature inducing differentiation, H-145 antigen increased, and became gradually dispersed in the cytoplasm, and its expression on the cell surface increased markedly during differentiation.
As a result, the antigen was distributed all over the cell after 12 hr, when the cells become committed to differentiation. These findings strongly suggest that quantitative expression of the antigen on the cell surface is needed for differentiation. These facts led us to investi-gate the relation between changes in distribution of H-145 antigen at 41°C, that is, transport of the antigen from the Golgi apparatus to the cell surface and myoblast fusion, using bafilomycin Al. On treatment with this drug, myoblast fusion was blocked dose-dependently, and H-145 antigen remained in the Golgi apparatus.
In this condition, quantitative increase in the antigen with differentiation was also suppressed as on culture of cells at the temperature not inducing differentiation (35.5°C) . Moreover, on removal of bafilomycin Al from the mediumafter 24 hr, the H-145 antigen became widely dispersed throughout the cytoplasm, and myoblast fusion began to occur after a constant lag time.
These results indicate that at 41°C, H-145 antigen must increase for myoblast fusion, and more than the constant amount of antigen is transported to and expressed on the cell surface. As reported previously, tyrosine kinase, the gene product of src, is activated at 35.5°C in QM-RSVcells (12). Thus some factor(s) related to transport of H-145 antigen may be inactived by phosphorylation at 35.5°C.
Bafilomycin Al has been shownto be a specific inhibitor of vacuolar H+-ATPase (1, 8, 21, 35) . The intracellular transport of newly synthesized prolactin is reported to be inhibited by bafilomycin Al, probably because bafilomycin Al inhibits vacuolar H+-ATPaseresulting in inhibition of acidification of maturing granules of prolactin (8). To ascertain whether transportation of H-145 antigen was inhibited by inhibition of H+-ATPase, we used another inhibitor of H+-ATPase, 2,3-butanedione.
As this compound also inhibited fusion of QM-RSVcells, the inhibition of transportation of H-145 antigen by bafilomycin Al may be due to inhibition of the H+-ATPase. In addition, we also examined effects of other agents which inhibit transportation of intracellular proteins, such as methylamine, monensin and chloroquine, on myoblast fusion. All of these inhibitors inhibited myoblast fusion, and by these inhibitors, H-145 antigen remained localized in the Golgi apparatus. These results also showed that transportation of H-145 antigen to the cell surface is prerequisite for myoblast fusion of QM-RSVcells. At 41°C, the temperature for differentiation, H-145 antigen synthesized de novo was expressed on the cell surface continuously. In the presence of bafilomycin Al, which inhibits fusion, transportation of the antigen was inhibited, and as a result, expression of the antigen on the cell surface was suppressed. Therefore, it seems necessary for myoblast fusion that morethan the constant amountof antigen must be integrated into the cell surface.
Bafilomycin Al suppressed creatine kinase activity to about half that in untreated cells at 41°C, but its effect on the enzymeactivity was less than that on myoblast fusion. These findings suggest that bafilomycin Al affects biochemical differentiation indirectly.
Molecular cloning of this antigen is in progress.
